JP2022525202A5 - - Google Patents
Info
- Publication number
- JP2022525202A5 JP2022525202A5 JP2021555469A JP2021555469A JP2022525202A5 JP 2022525202 A5 JP2022525202 A5 JP 2022525202A5 JP 2021555469 A JP2021555469 A JP 2021555469A JP 2021555469 A JP2021555469 A JP 2021555469A JP 2022525202 A5 JP2022525202 A5 JP 2022525202A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical product
- pharmaceutically acceptable
- product according
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819162P | 2019-03-15 | 2019-03-15 | |
| US62/819,162 | 2019-03-15 | ||
| PCT/IB2020/000177 WO2020188352A1 (en) | 2019-03-15 | 2020-03-13 | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525202A JP2022525202A (ja) | 2022-05-11 |
| JP2022525202A5 true JP2022525202A5 (https=) | 2023-02-13 |
Family
ID=71092560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555469A Pending JP2022525202A (ja) | 2019-03-15 | 2020-03-13 | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と１日あたりの投薬量 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11576915B2 (https=) |
| EP (1) | EP3938043A1 (https=) |
| JP (1) | JP2022525202A (https=) |
| KR (1) | KR20210139293A (https=) |
| CN (1) | CN113784717A (https=) |
| AU (1) | AU2020244278A1 (https=) |
| CA (1) | CA3133589A1 (https=) |
| MX (1) | MX2021011224A (https=) |
| WO (1) | WO2020188352A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11413287B2 (en) * | 2018-11-16 | 2022-08-16 | Altavant Sciences Gmbh | Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
| MX2021009055A (es) * | 2019-01-30 | 2021-10-22 | Altavant Sciences Gmbh | Pauta posológica y método para tratar la hipertensión arterial pulmonar con rodatristat etilo. |
| AU2020244278A1 (en) | 2019-03-15 | 2021-09-30 | Altavant Sciences Gmbh | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing |
| WO2023062595A1 (en) | 2021-10-14 | 2023-04-20 | Altavant Sciences Gmbh | Treatment of subjects having pulmonary arterial hypertension with rodatristat ethyl |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7875622B2 (en) * | 2007-07-11 | 2011-01-25 | Lexicon Pharmaceuticals, Inc. | Methods and compositions for treating pulmonary hypertension and related diseases and disorders |
| UA119247C2 (uk) * | 2013-09-06 | 2019-05-27 | РОЙВЕНТ САЙЕНСИЗ ҐмбГ | Спіроциклічні сполуки як інгібітори триптофангідроксилази |
| US9399741B2 (en) | 2013-10-09 | 2016-07-26 | Uop Llc | Methods and apparatuses for desulfurizing hydrocarbon streams |
| CA3119912A1 (en) * | 2018-11-14 | 2020-05-22 | Altavant Sciences Gmbh | A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (tph1) for treating diseases or disorders associated with peripheral serotonin |
| US11413287B2 (en) | 2018-11-16 | 2022-08-16 | Altavant Sciences Gmbh | Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
| WO2020128614A1 (en) | 2018-12-17 | 2020-06-25 | Altavant Sciences Gmbh | Method for treating interstital lung disease |
| WO2020128608A1 (en) | 2018-12-17 | 2020-06-25 | Altavant Sciences Gmbh | Compound for use in a method for treating sarcoidosis-associated pulmonary hypertension |
| MX2021009055A (es) | 2019-01-30 | 2021-10-22 | Altavant Sciences Gmbh | Pauta posológica y método para tratar la hipertensión arterial pulmonar con rodatristat etilo. |
| AU2020244278A1 (en) | 2019-03-15 | 2021-09-30 | Altavant Sciences Gmbh | A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing |
-
2020
- 2020-03-13 AU AU2020244278A patent/AU2020244278A1/en not_active Abandoned
- 2020-03-13 WO PCT/IB2020/000177 patent/WO2020188352A1/en not_active Ceased
- 2020-03-13 CN CN202080033296.0A patent/CN113784717A/zh active Pending
- 2020-03-13 EP EP20732658.8A patent/EP3938043A1/en not_active Withdrawn
- 2020-03-13 JP JP2021555469A patent/JP2022525202A/ja active Pending
- 2020-03-13 KR KR1020217031156A patent/KR20210139293A/ko not_active Abandoned
- 2020-03-13 US US16/818,236 patent/US11576915B2/en active Active
- 2020-03-13 MX MX2021011224A patent/MX2021011224A/es unknown
- 2020-03-13 CA CA3133589A patent/CA3133589A1/en active Pending
-
2023
- 2023-01-04 US US18/149,992 patent/US20240024316A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022507533A5 (https=) | ||
| JP2022525202A5 (https=) | ||
| US9771361B2 (en) | Inhibitors of influenza viruses replication | |
| JP7697885B2 (ja) | 化合物の製剤およびそれらの使用 | |
| CN100448439C (zh) | 用于头痛、偏头痛、恶心和呕吐的药物组合物 | |
| WO2015130966A1 (en) | Antiviral agents | |
| CN102389423A (zh) | 一种含有布洛芬钠盐的药用组合物 | |
| US20190233470A1 (en) | Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| CA2446748A1 (en) | Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods | |
| CN113784717A (zh) | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 | |
| EP4045058A1 (fr) | Utilisation de nictotinamide mononucléotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoïde et compositions correspondantes | |
| TW200306185A (en) | Combinations comprising EPOTHILONES and anti-metabolites | |
| CN100372533C (zh) | 腹泻为主大肠激惹综合征的治疗制剂 | |
| RU2358723C1 (ru) | Средство, обладающее антипохмельным действием, биологически активная добавка, фармацевтическая композиция, лекарственное средство и способ получения | |
| AU2013368298B2 (en) | Methods and compositions for administration of oxybutynin | |
| JP2018035165A (ja) | Ｓ−（＋）−フルルビプロフェンを含む原薬の調製物、医薬組成物、そして剤形 | |
| JP5376785B2 (ja) | 医薬組成物 | |
| JP2010536827A (ja) | ある種の炎症性障害の治療に有用なカルボニルアミノ誘導体 | |
| JP5376786B2 (ja) | 神経細胞賦活組成物 | |
| WO2016006621A1 (ja) | Ｐｇｄ２拮抗剤を含有するアレルギー性疾患に伴う症状の治療用医薬 | |
| JP6421873B2 (ja) | テノホビルジソプロキシルの新規塩 | |
| TW536400B (en) | Pharmaceutical composition for the treatment of immunodeficiency disease which cause by HIV infection | |
| TW200826923A (en) | A composition for the treatment and prevention of peptic ulcer | |
| KR20220014025A (ko) | 나파모스타트 메실레이트와 덱사메타손 또는 그 염을 유효성분으로 포함하는 약학적 조성물 |